CARDIFF ONCOLOGY INC

Cardiff Oncology Directors Flood into Shares as Low‑Price Offer Sparks “Buy Low, Insider High” Frenzy

Cardiff Oncology insider buy‑in signals confidence amid low‑price offering and onvansertib trial; investors see a buy‑low, insider‑high opportunity.

CARDIFF ONCOLOGY INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

16/07/2026, 22:18

4 minutes to read

Cardiff Oncology Directors Rally: Insider Option Buying Signals Confidence Amid Low‑End Stock Price

Cardiff Oncology insider buying spurs investor curiosity—insiders buy $1.29‑priced options, signaling confidence amid a low‑price, high‑risk backdrop.

CARDIFF ONCOLOGY INC
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

16/06/2026, 18:37

3 minutes to read